[Exogenous hypermineralocorticism caused by a nasal spray containing 9-alpha fluoroprednisolone]. 1984

L Virgolini, and O Geatti, and G Giunta

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007008 Hypokalemia Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed) Hypopotassemia,Hypokalemias,Hypopotassemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005477 Fluprednisolone A synthetic glucocorticoid with anti-inflammatory properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D014663 Nasal Decongestants Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) Decongestant,Decongestants,Nasal Decongestant,Vasoconstrictor Agents, Nasal,Vasoconstrictors, Nasal,Agents, Nasal Vasoconstrictor,Decongestant, Nasal,Decongestants, Nasal,Nasal Vasoconstrictor Agents,Nasal Vasoconstrictors

Related Publications

L Virgolini, and O Geatti, and G Giunta
January 1984, Minerva endocrinologica,
L Virgolini, and O Geatti, and G Giunta
January 1985, La Clinica terapeutica,
L Virgolini, and O Geatti, and G Giunta
June 1979, Lancet (London, England),
L Virgolini, and O Geatti, and G Giunta
September 1981, The American journal of medicine,
L Virgolini, and O Geatti, and G Giunta
June 1984, Human toxicology,
L Virgolini, and O Geatti, and G Giunta
January 1988, Medicina cutanea ibero-latino-americana,
L Virgolini, and O Geatti, and G Giunta
January 1987, Clinical neuropathology,
L Virgolini, and O Geatti, and G Giunta
September 1987, Minerva medica,
Copied contents to your clipboard!